Purpose: To investigate relationships between blood pressure (BP), ocular perfusion pressure (OPP), and intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) of different body mass index (BMI) classes. Methods: Data from participants of a prospective, longitudinal, single site, observational study were analyzed. Patients with a prior diagnosis of OAG completed 2 baseline visits (1 week apart) with follow-up visits every 6 months for 2 years. At each visit, BP, weight, height, and IOP were recorded for normal-weight n = 38), overweight n = 43), and obese (BMI ≥30; n = 34) patients: The BP was measured using automated ambulatory measurements after 5 minutes rest and IOP was measured using Goldmann applanation tonometry. Results: The IOP decreased from baseline to 2-year measurement in normal-weight (−1.5, 95% confidence interval [CI] −2.7 to −0.4), overweight (−1.9, 95% CI −3.4 to −0.4), and obese (−2.5, 95% CI −3.9 to −1.2) patients with OAG. Systolic BP (SBP) and OPP decreased from baseline to 2-year measurement in all 3 BMI categories, although not reaching statistical significance. In normal-weight patients, there was a significant, positive correlation between changes in IOP and SBP (r = 0.36, p = 0.0431). A significant, negative correlation was observed between changes in p = 0.0499) 
INTRODUCTION
Primary open-angle glaucoma (OAG) is a multifactorial optic neuropathy with characteristic progressive loss of retinal ganglion cells and visual field. Although increased intraocular pressure (IOP) is considered to be a major risk factor in the development of glaucoma, vascular elements, including systemic arterial blood pressure (BP) and ocular perfusion pressure (OPP), have also been implicated in the pathogenesis of OAG. Hypertension is defined as systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg and has an increased prevalence in individuals with a body mass index (BMI) of overweight (BMI 25.0-29.9) or obese (BMI ≥30) (1) . The association of high arterial BP with increases in IOP has been described in numerous studies; tions were made strictly by the primary ophthalmologists with no intervention from the research team. Two initial baseline measurements were performed 1 week apart, followed by visits every 6 months. These baseline measurements served as confirmation of both glaucomatous status and study measurement reliability. All examinations were performed in the same order, at the same time of day, for each patient. All subjects had open angles on gonioscopic examination and had secondary causes of glaucoma ruled out during recruitment. In each participant, one qualified eye was randomly assigned as the observational study eye. The inclusion criteria included age 30 years or older, OAG in the study eye as determined by a glaucoma specialist, best-corrected Early Treatment Diabetic Retinopathy Study visual acuity of 20/60 or better in the study eye, and acceptable reliability indexes in previous visual fields (VF) performed. The exclusion criteria included advanced VF damage consisting of a mean deviation worse than −15 dB, evidence of pseudoexfoliation or pigment dispersion, history of acute angle closure glaucoma or a narrow occludable angle (per history), history of intraocular trauma, and severe or progressive retinal disease such as retinal degeneration, diabetic retinopathy, retinal detachment, or any abnormality preventing reliable applanation tonometry. Height was measured in centimeters. Weight was measured in kilograms. The following equation was used to calculate the BMI: BMI = weight (kg)/height (m 2 ). The BMI was categorized as follows: normal weight (BMI 18.5-24.9), overweight (BMI 25.0-29.9), and obese (BMI ≥30) (1). Brachial artery BP was assessed after a 5-minute rest period using a calibrated automated sphygmomanometer (CVS, Woonsocket, Rhode Island, USA) at the beginning of each study visit. Hypertension is defined as SBP ≥140 mm Hg or DBP ≥90 mm Hg (1). Mean arterial pressure (MAP) was calculated using the following equation: MAP = DBP + 1/3(SBP − DBP). Intraocular pressure was measured with Goldmann applanation tonometry. Ocular perfusion pressure was calculated from the measured arterial BP and IOP measurements. The following equation was used to calculate the OPP: OPP = 2/3[DBP + 1/3(SBP − DBP)] − IOP. Descriptive statistics including mean and standard error were computed. The mean change from baseline to 2 years was considered statistically significant if the 95% confi-more recently, this relationship has been reported in Asian populations, including the Kumejima and Tajimi Studies in Japan, the Beijing Eye Study, and the Central Indian Eye and Medical Study (2) (3) (4) (5) . There are two theories that exist to explain a mechanism for the proposed relationship between BP and IOP (6) . The first theory speculates that the autonomic nervous system, an important regulator of BP, may affect the circadian rhythm of aqueous humor secretion, which should lead to corresponding changes in IOP (7) . The second theory suggests that angiotensin converting enzyme (ACE), which is involved in the renin angiotensin system that influences BP, may also decrease IOP, possibly by inhibiting cholinesterase activity or by increasing prostaglandin synthesis (8) . This is reinforced by studies where ACE inhibitors are used to reduce IOP in rabbits (8) . Ocular perfusion pressure is defined as the difference between arterial pressure and venous pressure, which is equal to or slightly greater than IOP (6) . In large population-based trials, including the Los Angeles Latino Eye and Barbados Studies, reduced OPP has been found to be associated with both the incidence and prevalence of glaucoma (9, 10). Mechanistically, reduced ocular blood flow may be secondary to elevated IOP and/or reduced BP, or it could be the consequence of a primary insult to the ocular vasculature, such as vasospasm and/or faulty vascular autoregulation (6) . The purpose of this analysis through the Indianapolis Glaucoma Progression Study (IGPS) is to investigate the relationship between BP, OPP, and IOP in different BMI classes of individuals with OAG.
MATERIALS AND METHODS
Patient data originated from the IGPS. The IGPS is a prospective, longitudinal, single-site observational study of patients with OAG from Indianapolis, Indiana, and its surrounding areas conducted at Indiana University Hospital. All study procedures conformed to the tenets of the Declaration of Helsinki and were approved by the institutional review board at the Indiana University School of Medicine. Subjects signed informed consents prior to study entry. Participants had received the diagnosis of OAG from a glaucoma specialist prior to enrollment in the IGPS, and were currently under the care of the diagnosing physician. Treatment decisions regarding glaucoma medica-Blood pressure, ocular perfusion pressure, and BMI in glaucoma dence interval (CI) did not include 1. Pearson correlation coefficients were determined to compare changes in measurements from baseline to 2 years between the study measurements. p Values of less than 0.05 were considered statistically significant.
RESULTS
After 2 years of follow-up, data from 38 normal-weight, 43 overweight, and 34 obese individuals at baseline were analyzed. By 2 years, 5 patients increased from normal weight to overweight, 3 patients decreased from overweight to normal weight, and 3 patients decreased from obese to overweight. The demographics of the study population at baseline are presented in Table I . The IOP decreased from baseline to 2-year measurement in normal-weight (−1.5, 95% CI −2.7 to −0.4), overweight (−1.9, 95% CI −3.4 to −0.4), and obese (−2.5, 95% CI −3.9 to −1.2) patients with OAG ( Fig. 1) . The SBP and OPP decreased from baseline to 2-year measurement in all 3 BMI categories, although not reaching statistical significance. This is presented in Table II . In normal-weight patients, there was a significant, positive correlation between changes in IOP and SBP (r = 0.36, p = 0.0431), as shown in Figure 2 . However, no correlation between IOP and SBP changes was observed in the overweight (r = −0.08, p = 0.65) or the obese population (r = 0.09, p = 0.64). No significant correlation was found between DBP and IOP. Conversely, there was a significant, negative correlation between changes in IOP and OPP in overweight (r = −0.56, p = 0.0002) and obese (r = −0.38, p = 0.0499) patients, as demonstrated in Figure 3 . No correlation between IOP and OPP was observed in normal-weight patients (r = 0.03, p = 0.89).
DISCUSSION
This study analyzed a subset of the IGPS data to explore relationships between BP, OPP, IOP, and BMI in patients with glaucoma. Significant correlations were observed be tween 
SBP and IOP in normal-weight individuals and between OPP and IOP in overweight and obese patients.
The changes that occurred in BP and IOP from baseline to 2 years are likely attributable to the medications that the patients were using. Beta-blockers are utilized for the treatment of hypertension as well as OAG and thus may have overlapping systemic and ophthalmic effects. The percentage of individuals taking various medications for managing BP at baseline and 2 years are listed in Table  III , and the percentage of those taking various medications for OAG at baseline and 2 years are listed in Table IV .
Results of this study demonstrated that in normal-weight individuals with OAG, changes in SBP were positively correlated to changes in IOP after 2 years. This association Blood pressure, ocular perfusion pressure, and BMI in glaucoma A negative correlation between changes in OPP and changes in IOP was found in overweight and obese patients. This correlation was not observed in normal-weight individuals. Many epidemiologic studies have investigated the role of OPP in OAG, but without relating OPP to IOP in different BMI classes. The important determination in these studies was that a reduced OPP is indeed a risk factor for OAG (9, 10, 13, 16, 17) . The Barbados Study reported that lower systolic, diastolic, and mean perfusion pressures were risk factors for long-term OAG incidence in an African-descent population (10) . The Latino Eye Study found that low systolic, diastolic, and mean perfusion pressures were associated with an increased prevalence of OAG in adult Latinos (9) . The Egna-Neumarkt and Baltimore Eye Studies reported an increased risk of OAG with decreased diastolic perfusion pressures (13, 16) . The Early Manifest Glaucoma Trials identified lower systolic perfusion pressure as a predictor for OAG progression (17) . One limitation of the current analysis is that we did not explore patients of African descent vs European descent separately, although results from this analysis are underway and will be presented in a future article. The results of our study suggest that the relationship between SBP and IOP may be more important than that between OPP and IOP in the normal-weight population. In contrast, the relationship between OPP and IOP may be more important in the overweight and obese population. A possible reason for this discrepancy may be that normal-weight individuals are less likely to have hypertension, while overweight and obese individuals have a greater tendency toward elevated BP (1). Individuals with hypertension may have pathologic changes of intraocular blood vessels; thus, their eyes may be more sensitive to changes in OPP (11) . On the other hand, eyes of normal-weight individuals may contain healthier, more resilient blood vessels that are adaptable to changes in OPP. However, this may not be applicable to our study due to the similarity in SBP between normal-weight and overweight individuals at baseline. Another limitation is that the BP measurements in this study were only mildly elevated above normal and the length of time that the BP may have been elevated before being measured at baseline is unknown. Further investigation is required to help explain this incongruity among the BMI classes. The longitudinal nature of the IGPS with 6-month followup for 2 years and continuing onward for future analysis makes our study unique compared to other epidemiologic studies in that multiple other recent studies have been conducted for approximately 1 year or less (2, 3, 5, 9). The (15) . However, the only statistically significant values stated in this article were an increase in mean IOP in the right eye by 0.28 mm Hg (95% CI 0.23-0.34) for each 10 mm Hg increase in SBP and by 0.52 mm Hg (95% CI 0.40-0.66) for each 10 mm Hg increase in DBP (15) .
Blue Mountain Eye Study and Baltimore Eye Study are similar to our study in that they were also longitudinal in nature, spanning 2 and 3 years, respectively (15, 16) . Currently there is a lack of data describing the relationship between BP and IOP in American populations, despite the prevalence of hypertension in the overweight and obese populations in the United States. It could be exceedingly useful to establish a relationship between these 2 factors as hypertension could be managed through lifestyle and medical treatment. That is, BP could potentially be a modifiable risk factor for ocular hypertension and/or OAG. In summary, a significant, positive correlation between SBP and IOP was observed in normal-weight individuals, while a significant, negative correlation between OPP and IOP was observed in the overweight and obese BMI categories. As the IGPS study continues to gather data, relationships between systemic and ocular biometric factors may be further elucidated.
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